Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Type 1 diabetes stories

Oct 29, 2026

Study links type 1 diabetes immune changes to potential cancer protection

New research published in The Journal of Immunology reveals how high blood sugar and type 1 diabetes may protect against certain cancers including melanoma, breast and colon cancer. The findings could inform development of new cancer immunotherapy treatments by explaining the previously mysterious association between T1D and decreased cancer risk.

Oct 29, 2026·1 source
00
Sep 26, 2026

Study links ultra-processed foods to increased risk of chronic disease and death

A new analysis published in Family Medicine and Community Health found that greater consumption of ultra-processed foods significantly increases the risk for multiple chronic diseases and death. The findings align with prior research connecting ultra-processed foods to adverse health outcomes including cancer, type 2 diabetes, and cardiovascular disease.

Sep 26, 2026·5 sources
00
Jul 9, 2026

China Updates National Essential Medicines List for First Time in Eight Years, Adding Semaglutide and 115 Other Drugs as Domestic Oral GLP-1 Treatments Show Progress

On July 9, 2026, China's National Health Commission added injectable semaglutide and 115 other drugs to its National Essential Medicines List — the first update in eight years — expanding the catalog to 794 medicines effective September 1, 2026, while domestic oral GLP-1 candidates from Hengrui and Gan & Lee advanced in clinical trials.

Jul 9, 2026·5 sources
00

Top claims

  • ▪Tumor growth in hyperglycemic mice was significantly reduced compared to diabetic mice receiving insulin and mice with normal blood sugar levels.
  • ▪Blood samples from people with hyperglycemia showed an increased activation of the same IGF1-IGF1R signaling pathway observed in hyperglycemic mice.
  • ▪Researchers determined that high blood glucose metabolically rejuvenates CD8+ T cells for improved tumor control through the IGF1-IGF1R cellular signaling axis.

Subtopics

Cancer2Cancer & Oncology2Biomedical research1Blood sugar & insulin1Cancer immunotherapy1Cancer research1Cardiovascular diseases1China1Chronic disease1Drug Policy, Pricing & Approval1GLP-1 drugs1GLP-1 medications1Immunology1Lifestyle, Wellness and Nutrition1Nutrition1Public health research1Public healthcare1Ultra-processed foods1Weight loss medications & GLP-1 drugs1Weight management1

Related timelines

Trump administration

161 stories

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Russia-Ukraine war

136 stories